News

IR Sant Pau Leads New Basic and Translational Research Network on Synaptic Circuits and Nervous System Diseases in Spain

The Sant Pau Research Institute (IR Sant Pau) has secured funding for the creation of the Network for the Integrative Study of Synaptic Circuits and Their Role in Disease. This network will be coordin...

Letter in The Lancet Celebrates Arrival of Lecanemab as Start of Paradigm Shift in Europe, Questions EMA’s Veto of Donanemab

A recently published letter in The Lancet, signed by Dr. Juan Fortea and leading European experts in Alzheimer’s disease, celebrates the European Commission’s approval of lecanemab as a key milest...

An Experimental Immunotherapy Reverses Heart Energy Damage Caused by Cholesterol

An international team of researchers has discovered how cholesterol can disrupt the internal functioning of the heart by accumulating in the mitochondria of cardiomyocytes. They have also developed an...

The Sant Pau Research Institute Presents its New Strategic Plan 2025-2030

The Sant Pau Research Institute (IR Sant Pau) presented its new Strategic Plan 2025-2030 this Tuesday, in an event open to all research and healthcare staff. The plan will define the...

Lipid Alterations Linked to Cardiovascular Risk Detected in People with Type 2 Diabetes

A recent study has identified specific alterations in lipid metabolism associated with subclinical atherosclerosis in individuals with type 2 diabetes. This silent condition, known as atherosclerosis,...